LBA
NVS icon

Lowell Blake & Associates’s Novartis NVS Stock Holding History

Lowell Blake & Associates’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$2.12M Sell
20,785
-620
-3% -$62.9K 0.6% 32
2023
Q2 		$2.16M Sell
21,405
-1,467
-6% -$147K 0.63% 30
2023
Q1 		$2.1M Sell
22,872
-4,993
-18% -$436K 0.66% 30
2022
Q4 		$2.53M Sell
27,865
-12,640
-31% -$1.06M 0.84% 28
2022
Q3 		$3.08M Sell
40,505
-4,626
-10% -$383K 1.21% 27
2022
Q2 		$3.81M Sell
45,131
-22,947
-34% -$2.01M 1.47% 24
2022
Q1 		$5.97M Sell
68,078
-1,694
-2% -$147K 2.25% 17
2021
Q4 		$6.1M Buy
69,772
+3,463
+5% +$288K 2.4% 19
2021
Q3 		$5.42M Buy
66,309
+1,272
+2% +$114K 2.52% 17
2021
Q2 		$5.93M Sell
65,037
-514
-0.8% -$45.8K 2.73% 17
2021
Q1 		$5.6M Buy
65,551
+18,963
+41% +$1.7M 2.87% 16
2020
Q4 		$4.4M Buy
46,588
+2,330
+5% +$204K 3.25% 16
2020
Q3 		$3.85M Buy
44,258
+3,088
+8% +$268K 3.1% 16
2020
Q2 		$3.6M Buy
41,170
+3,951
+11% +$341K 3.44% 12
2020
Q1 		$3.07M Buy
37,219
+2,867
+8% +$256K 3.94% 10
2019
Q4 		$3.25M Buy
+34,352
New +$3.08M 3.6% 10

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Lowell Blake & Associates's NVS Position: Q3 2023 in Review

Lowell Blake & Associates reduced its Novartis (NVS) stake by 2.9% in Q3 2023, selling an estimated $62.9K and leaving 20,785 shares worth $2.12M. The position accounts for 0.6% of the portfolio, ranked #32.

Lowell Blake & Associates first reported a position in NVS in Q4 2019 and has held it in 16 quarters since. The position peaked at $6.1M in Q4 2021. 1,222 funds tracked by Wall St. Rank hold NVS as of Q3 2023.

  • Lowell Blake & Associates held 20,785 shares of Novartis worth $2.12M as of Q3 2023.
  • Lowell Blake & Associates sold 620 Novartis shares in Q3 2023, an estimated $62.9K.
  • Novartis made up 0.6% of Lowell Blake & Associates's portfolio in Q3 2023, its #32 holding.
  • Lowell Blake & Associates first reported a position in Novartis in Q4 2019 and has held it in 16 quarters since.
  • Lowell Blake & Associates's Novartis position peaked at $6.1M in Q4 2021.
  • 1,222 funds tracked by Wall St. Rank held Novartis as of Q3 2023.

Based on Lowell Blake & Associates's 13F filing for Q3 2023, filed 13 Nov 2023.